You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
Turn on more accessible mode
Turn off more accessible mode
Skip Ribbon Commands
Skip to main content
Turn off Animations
Turn on Animations
SharePoint
Sign In
Follow
ECC-PICO
Currently selected
SEERS
2019 Cape Town Meeting Documents
PublicComment
It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again.
Libraries
2018 Chicago Meeting Documents
2017 ILCOR Anaheim Meeting Documents
PICO Search Re-runs
2017 ILCOR Adelaide Meeting Documents
Evidence Review Process
Newcastle
Lists
Recent
Currently selected
ILCOR 2019 Cape Town Meeting Documents
2018 Chicago Meeting Documents
Feedback
If you have any comments or questions on this page, please email us at:
ILCORC2015@heart.org
Postresuscitation Antiarrhythmic Drugs
Question Type:
Intervention
Digital Worksheet:
Open the Digital Worksheet to find more information on the development of this CoSTR.
Full Question:
Among adults with ROSC after cardiac arrest in any setting (P), does do prophylactic antiarrhythmic drugs given immediately after ROSC (I), compared with compared with not giving antiarrhythmic drugs (C), change Survival with Favorable neurological/functional outcome at discharge, 30 days, 60 days, 180 days AND/OR 1 year, development of cardiac arrest, Survival only at discharge, 30 days, 60 days, 180 days AND/OR 1 year, recurrence of VF, incidence of arrhythmias (O)?
Consensus on Science:
β-Blockers (I) Versus No β-Blockers (C) For the critical outcome of survival at 6 months, we have identified very-low-quality evidence (downgraded for serious risk of bias, indirectness, and imprecision) from 1 observational study of 98 patients resuscitated from OHCA showing a higher rate of survival with administration of β-blockers (metoprolol or bisoprolol) for 72 hours after ROSC compared with no drug (55.7% versus 21.1%; P
Treatment Recommendation:
We make no recommendation about the routine prophylactic use of antiarrhythmic drugs post after ROSC (GRADE used for evidence evaluation and synthesis only, very low confidence in effect estimate). Values, Preferences, and Task Force Insights The available data were too limited to have any confidence in any effect, and, therefore, no recommendation is made. We also place value on avoiding known side effects of medications when the treatment effect was unproven or unknown. The studies evaluated were all observational, and no causal relation could be determined. Moreover, they were performed before changes in current practice (ie, currently amiodarone is used during cardiac arrest more than lidocaine).
CoSTR Attachments:
CoSTR Statement - ALS 493 Antiarrhythmic drugs post resuscitation 20150110.docx
Pellis - Grade Table.docx
Contact Us
If you have any comments or questions on this page, please email us at:
ILCORC2015@heart.org